Dupilumab in Adults With Moderate to Severe Atopic Dermatitis: A 5-Year Open-Label Extension Study.
Beck LA, Bissonnette R, Deleuran M, Nakahara T, Galus R, Coleman A, Gherardi G, Xiao J, Dingman R, Xu C, Avetisova E, Dubost-Brama A, Shabbir A.
Beck LA, et al. Among authors: avetisova e.
JAMA Dermatol. 2024 Aug 1;160(8):805-812. doi: 10.1001/jamadermatol.2024.1536.
JAMA Dermatol. 2024.
PMID: 38985486
Free PMC article.